Biodegradable Dextran-Maleic Acid Hydrogel
- Detailed Technology Description
- A biodegradable hydrogel that is easy to process and exhibits improved swelling properties.
- Others
-
Patents: 2,339,166; 6,476,204; EP1147148; 69925757.03-08;
- *Abstract
-
A new class of biodegradable polysaccharide-based hydrogel was developed for use in a range of medical applications including controlled drug release, surgical implants, and wound healing. The hydrogels can absorb large quantities of water and exhibit improved swelling properties in water without loss of mechanical and structural integrity associated with increasing degrees of substitution.
By altering the ratios of the two components that make up the hydrogels, their properties can be changed, e.g. to vary the time release of molecules encapsulated in the gel. In addition, the gels are relatively easy and inexpensive to process since their precursors dissolve in common organic solvents.
Potential Applications:
- controlled drug release
- artificial skins
- wound dressings
- surgical implants
- tissue culture plates
- gene therapy vector delivery systems
Advantages:
- Made of FDA-approved biodegradable materials
- Ease of processing (i.e. less costly)
- Improved swelling
- Structural integrity
- Tunable properties based on ratio of components
- *Licensing
- Martin Teschlmt439@cornell.edu(607) 254-4454
- Country/Region
- USA
